There’s no question that the area earned its reputation as the international economy’s problem child, but, according to a February 3 report from the Credit Suisse Research Institute entitled “Latin America: The Long Road,” the region has been advancing over the past two decades and is poised to extend its gains. Poverty has declined, inflation has slowed and political stability has improved. Not only is Latin America no longer a trigger of global disorder, it has proved resilient to financial crises generated elsewhere, including the Great Recession. That’s certainly a break from the region’s volatile past, when disturbances in the world economy routinely had a very negative impact on its domestic economies. “The last 20 years have been a crucial period as they represent the most radical change in the political, macro and social structures of Latin America in the last two centuries,” says the report.
Most Latin American countries have either transformed or are in the midst of transforming their economies away from a dependence on commodities, which historically left them vulnerable to the volatile fluctuations of global prices for oil, food, metals and other raw materials. Since the early 1990s, many have been modernizing their economies by strengthening their service and manufacturing sectors, approving key structural reforms and boosting long-term investment. Latin America now exports a higher proportion of its goods to Asian economies, resulting in a more diversified roster of trading partners, inflation has come under control, and political regimes in many countries have become more democratic.
The upshot? Now that an extended global commodity boom is waning, the region isn’t at risk like it was the last time that happened, in the 1980s. Even though the collective current account balance recently hit deficit territory, several other indicators suggest that Latin America is well positioned to absorb external shocks. The region boasts an external debt-to-exports ratio of around 100 percent, which is half its level in 1980 and similar to other emerging markets. The external debt-to-GDP ratio of 24.5 percent is only 4 percent above its 30-year low, total reserves excluding gold were at a near-record high of 60 percent of external debt at the end of 2012, and the capital-to-assets ratio of the region’s banks was 10.3 percent in 2012, compared with an OECD average of 7.4 percent.
That spells opportunity for investors, in our view, especially those in the consumer goods, financial services and energy sectors. Growth in the region has fueled a burgeoning middle class, which grew by 50 percent between 2003 and 2009, from 103 to 152 million people. Credit Suisse expects that upward social mobility to persist, giving consumers more purchasing power and prompting them to buy more sophisticated—and therefore more valuable—goods and services. Greater Internet coverage is fueling more opportunities for e-commerce, and an expanding economy amid slow inflation should bring throngs of new customers to the financial services industry. To top it off, recent legislation to end Mexico’s state oil monopoly, along with plans by Brazilian energy company Petrobras to double production by 2020, should fuel growth in the energy sector.
Still, the regional economy isn’t without its weaknesses. Per capita GDP remains inferior to that of the developed world, the level of technological innovation is low, and doing business in many countries can still be a red tape-filled bureaucratic jungle. And consider Latin America’s total investment in infrastructure—just 2.1 percent of GDP between 2003 and 2012, roughly half of the minimum necessary to sustain economic growth of 4.5 percent, according to the United Nations Economic Commission for Latin America. (Compare that to China, which invested around 13 percent of its GDP, or even India, which came in at 5 percent.) Two of the region’s largest countries, Mexico and Brazil, have recently announced plans to woo private investors to build roads, ports, bridges and airports, but whether they will succeed remains to be seen.
Latin America is not a monolith, of course, and there are vast disparities among its economies. Chile, Peru and Panama, for example, score in the top ranges of Credit Suisse’s adaptation of the so-called misery index, which factors in economic growth, the inflation rate and the unemployment rate. Argentina and Venezuela are in the bottom 30 percent. And even as Brazil’s middle class grew to 50 percent of the population from 39 percent between 2002 and 2009, Mexico, the region’s second largest economy, only saw an increase of 35 to 39 percent between 2002 and 2011.
For a long time, it seemed that economic news out of Latin America was always bad—the only question was how bad it was going to be. For the time being, those days are over, and the region is more likely to be garnering praise rather than prompting lectures from the rest of the world. “By any reference to its own history, Latin America’s performance during and after the Great Crisis has been remarkable,” says former Mexican President Ernesto Zedillo in an introduction to the report. “However, it would be a terrible mistake for Latin American governments and societies to be complacent about the challenges in front of them.”
for more info click here:
http://blog.empowernetwork.com/blog/bootcamp-day-2-dao-of-blogging-and-getting-traffic?id=1210296
After
over a decade of working in the field and helping patients
successfully, the answer lies in the key difference between Lyme disease
and what we call Chronic Lyme disease complex. In most of the cases, we
see unfortunate patients given the diagnosis of Lyme disease, who were
prescribed antibiotics and attained very short term lived results with
mild improvement to say the least. However, it’s the only thing that
helped them at all. Patients believe that if they have the infection and
receive antibiotics, that it’s game over. This is certainly not the
case with Chronic Lyme disease!
Many conventional doctors will often miss the Lyme disease diagnosis all together due to not being well-informed on CDC’s (Centers of Disease and Control) failed testing criteria. Unlike many other infections, Lyme disease does not involve one straight forward lab test: in fact it involves a battery of tests to include genetic bands, immunity coupled with thorough medical history and confirmatory symptoms. Finally, when the diagnosis is made, antibiotics are almost always prescribed. The journal of Clinical Infectious disease published a study headed by Dr. Raphael B. Stricker that concluded that prolonged antibiotic therapy may be useful and justifiable in patients with persistent symptoms of Lyme disease and co-infections with tick-borne agents. However, another opposing study was conducted by Department of Neurology, University Medical Center at Stony Brook, Stony Brook, NY:
After receiving either 28 days of ceftriaxone (2 g per day) or placebo, the investigators found that there was a modest benefit with a lower fatigue score among those receiving ceftriaxone, although there was no change in the other end points, such as neurocognitive function or the CSF biomarker. Because of serious adverse effects, 4 (7%) of 55 patients were hospitalized with complications of intravenous therapy; study investigators concluded that parental antibiotic therapy could not be recommended, because the single subjective improved measure could not be justified against the considerable complication rate (2).
Taking into account that the antibiotic selections were different in the above studies, from a clinical perspective these outcomes are conflicting and confusing for patients. It all comes back to knowing the difference between “Lyme disease” and Chronic Lyme disease complex. Lyme disease in a vacuum is the infection of Borrelia (a spirochete that is most commonly transmitted by ticks). However, we define Chronic Lyme disease Complex or CLDC as: involving one or more factors: Lyme disease (as anchoring infection); its confection’s; the reactivation of dormant infections, such as viruses, fungal and parasitic infections; and or an immune compromised state that can be further complicated by heavy metal toxicity, chemical toxicities, essential nutritional deficiencies and structural impairments as part of the etiology of the chronic disease. Lyme disease Complex presents itself as a multifaceted medical puzzle that cannot be simply solved with only oral or IV antibiotics alone. Point being, in a medical culture where it’s difficult to find Lyme literate physicians that can treat you properly, it becomes almost impossible to find a doctor that treats this complex syndrome in an organized, comprehensive manner.
Our group has been working on solving this puzzle for many years. It starts with a proper diagnosis and treatment of all the infections involved: viral, fungal and parasitic co-infections that are often times more difficult to treat than the Lyme disease (Borrelia) itself. All these infections are connected and communicate with each other within your body; if one goes down the other up-regulates its replication until the vicious cycle is broken. Next, an in-depth functional medicine approach is implemented to correct all of the nutritional and amino acid imbalances while addressing old scar tissue, injuries and trauma that the body has suffered. Furthermore, selected medications are delivered in a proprietary method to cross the blood brain barrier and toxic metabolites removed from the central nervous system. This is all done while rebuilding immunity and restoring health. So many patients are confused when it comes to receiving treatment. When you don’t treat Lyme disease complex you leave way too many health issues on the table that are unresolved for the patient; it’s no wonder people don’t get well! In the end, it’s all about the personalized, integrative medical approach that works best for your individual case and getting the health you deserve. If you have any questions about Lyme disease or your current health condition, don’t hesitate to contact us. - See more at: http://envita.com/lyme-disease/stop-treating-lyme-disease-and-treat-the-complex#sthash.tcU2zJze.dpuf
Many conventional doctors will often miss the Lyme disease diagnosis all together due to not being well-informed on CDC’s (Centers of Disease and Control) failed testing criteria. Unlike many other infections, Lyme disease does not involve one straight forward lab test: in fact it involves a battery of tests to include genetic bands, immunity coupled with thorough medical history and confirmatory symptoms. Finally, when the diagnosis is made, antibiotics are almost always prescribed. The journal of Clinical Infectious disease published a study headed by Dr. Raphael B. Stricker that concluded that prolonged antibiotic therapy may be useful and justifiable in patients with persistent symptoms of Lyme disease and co-infections with tick-borne agents. However, another opposing study was conducted by Department of Neurology, University Medical Center at Stony Brook, Stony Brook, NY:
After receiving either 28 days of ceftriaxone (2 g per day) or placebo, the investigators found that there was a modest benefit with a lower fatigue score among those receiving ceftriaxone, although there was no change in the other end points, such as neurocognitive function or the CSF biomarker. Because of serious adverse effects, 4 (7%) of 55 patients were hospitalized with complications of intravenous therapy; study investigators concluded that parental antibiotic therapy could not be recommended, because the single subjective improved measure could not be justified against the considerable complication rate (2).
Taking into account that the antibiotic selections were different in the above studies, from a clinical perspective these outcomes are conflicting and confusing for patients. It all comes back to knowing the difference between “Lyme disease” and Chronic Lyme disease complex. Lyme disease in a vacuum is the infection of Borrelia (a spirochete that is most commonly transmitted by ticks). However, we define Chronic Lyme disease Complex or CLDC as: involving one or more factors: Lyme disease (as anchoring infection); its confection’s; the reactivation of dormant infections, such as viruses, fungal and parasitic infections; and or an immune compromised state that can be further complicated by heavy metal toxicity, chemical toxicities, essential nutritional deficiencies and structural impairments as part of the etiology of the chronic disease. Lyme disease Complex presents itself as a multifaceted medical puzzle that cannot be simply solved with only oral or IV antibiotics alone. Point being, in a medical culture where it’s difficult to find Lyme literate physicians that can treat you properly, it becomes almost impossible to find a doctor that treats this complex syndrome in an organized, comprehensive manner.
Our group has been working on solving this puzzle for many years. It starts with a proper diagnosis and treatment of all the infections involved: viral, fungal and parasitic co-infections that are often times more difficult to treat than the Lyme disease (Borrelia) itself. All these infections are connected and communicate with each other within your body; if one goes down the other up-regulates its replication until the vicious cycle is broken. Next, an in-depth functional medicine approach is implemented to correct all of the nutritional and amino acid imbalances while addressing old scar tissue, injuries and trauma that the body has suffered. Furthermore, selected medications are delivered in a proprietary method to cross the blood brain barrier and toxic metabolites removed from the central nervous system. This is all done while rebuilding immunity and restoring health. So many patients are confused when it comes to receiving treatment. When you don’t treat Lyme disease complex you leave way too many health issues on the table that are unresolved for the patient; it’s no wonder people don’t get well! In the end, it’s all about the personalized, integrative medical approach that works best for your individual case and getting the health you deserve. If you have any questions about Lyme disease or your current health condition, don’t hesitate to contact us. - See more at: http://envita.com/lyme-disease/stop-treating-lyme-disease-and-treat-the-complex#sthash.tcU2zJze.dpuf
After
over a decade of working in the field and helping patients
successfully, the answer lies in the key difference between Lyme disease
and what we call Chronic Lyme disease complex. In most of the cases, we
see unfortunate patients given the diagnosis of Lyme disease, who were
prescribed antibiotics and attained very short term lived results with
mild improvement to say the least. However, it’s the only thing that
helped them at all. Patients believe that if they have the infection and
receive antibiotics, that it’s game over. This is certainly not the
case with Chronic Lyme disease!
Many conventional doctors will often miss the Lyme disease diagnosis all together due to not being well-informed on CDC’s (Centers of Disease and Control) failed testing criteria. Unlike many other infections, Lyme disease does not involve one straight forward lab test: in fact it involves a battery of tests to include genetic bands, immunity coupled with thorough medical history and confirmatory symptoms. Finally, when the diagnosis is made, antibiotics are almost always prescribed. The journal of Clinical Infectious disease published a study headed by Dr. Raphael B. Stricker that concluded that prolonged antibiotic therapy may be useful and justifiable in patients with persistent symptoms of Lyme disease and co-infections with tick-borne agents. However, another opposing study was conducted by Department of Neurology, University Medical Center at Stony Brook, Stony Brook, NY:
After receiving either 28 days of ceftriaxone (2 g per day) or placebo, the investigators found that there was a modest benefit with a lower fatigue score among those receiving ceftriaxone, although there was no change in the other end points, such as neurocognitive function or the CSF biomarker. Because of serious adverse effects, 4 (7%) of 55 patients were hospitalized with complications of intravenous therapy; study investigators concluded that parental antibiotic therapy could not be recommended, because the single subjective improved measure could not be justified against the considerable complication rate (2).
Taking into account that the antibiotic selections were different in the above studies, from a clinical perspective these outcomes are conflicting and confusing for patients. It all comes back to knowing the difference between “Lyme disease” and Chronic Lyme disease complex. Lyme disease in a vacuum is the infection of Borrelia (a spirochete that is most commonly transmitted by ticks). However, we define Chronic Lyme disease Complex or CLDC as: involving one or more factors: Lyme disease (as anchoring infection); its confection’s; the reactivation of dormant infections, such as viruses, fungal and parasitic infections; and or an immune compromised state that can be further complicated by heavy metal toxicity, chemical toxicities, essential nutritional deficiencies and structural impairments as part of the etiology of the chronic disease. Lyme disease Complex presents itself as a multifaceted medical puzzle that cannot be simply solved with only oral or IV antibiotics alone. Point being, in a medical culture where it’s difficult to find Lyme literate physicians that can treat you properly, it becomes almost impossible to find a doctor that treats this complex syndrome in an organized, comprehensive manner.
Our group has been working on solving this puzzle for many years. It starts with a proper diagnosis and treatment of all the infections involved: viral, fungal and parasitic co-infections that are often times more difficult to treat than the Lyme disease (Borrelia) itself. All these infections are connected and communicate with each other within your body; if one goes down the other up-regulates its replication until the vicious cycle is broken. Next, an in-depth functional medicine approach is implemented to correct all of the nutritional and amino acid imbalances while addressing old scar tissue, injuries and trauma that the body has suffered. Furthermore, selected medications are delivered in a proprietary method to cross the blood brain barrier and toxic metabolites removed from the central nervous system. This is all done while rebuilding immunity and restoring health. So many patients are confused when it comes to receiving treatment. When you don’t treat Lyme disease complex you leave way too many health issues on the table that are unresolved for the patient; it’s no wonder people don’t get well! In the end, it’s all about the personalized, integrative medical approach that works best for your individual case and getting the health you deserve. If you have any questions about Lyme disease or your current health condition, don’t hesitate to contact us. - See more at: http://envita.com/lyme-disease/stop-treating-lyme-disease-and-treat-the-complex#sthash.tcU2zJze.dpuf
Many conventional doctors will often miss the Lyme disease diagnosis all together due to not being well-informed on CDC’s (Centers of Disease and Control) failed testing criteria. Unlike many other infections, Lyme disease does not involve one straight forward lab test: in fact it involves a battery of tests to include genetic bands, immunity coupled with thorough medical history and confirmatory symptoms. Finally, when the diagnosis is made, antibiotics are almost always prescribed. The journal of Clinical Infectious disease published a study headed by Dr. Raphael B. Stricker that concluded that prolonged antibiotic therapy may be useful and justifiable in patients with persistent symptoms of Lyme disease and co-infections with tick-borne agents. However, another opposing study was conducted by Department of Neurology, University Medical Center at Stony Brook, Stony Brook, NY:
After receiving either 28 days of ceftriaxone (2 g per day) or placebo, the investigators found that there was a modest benefit with a lower fatigue score among those receiving ceftriaxone, although there was no change in the other end points, such as neurocognitive function or the CSF biomarker. Because of serious adverse effects, 4 (7%) of 55 patients were hospitalized with complications of intravenous therapy; study investigators concluded that parental antibiotic therapy could not be recommended, because the single subjective improved measure could not be justified against the considerable complication rate (2).
Taking into account that the antibiotic selections were different in the above studies, from a clinical perspective these outcomes are conflicting and confusing for patients. It all comes back to knowing the difference between “Lyme disease” and Chronic Lyme disease complex. Lyme disease in a vacuum is the infection of Borrelia (a spirochete that is most commonly transmitted by ticks). However, we define Chronic Lyme disease Complex or CLDC as: involving one or more factors: Lyme disease (as anchoring infection); its confection’s; the reactivation of dormant infections, such as viruses, fungal and parasitic infections; and or an immune compromised state that can be further complicated by heavy metal toxicity, chemical toxicities, essential nutritional deficiencies and structural impairments as part of the etiology of the chronic disease. Lyme disease Complex presents itself as a multifaceted medical puzzle that cannot be simply solved with only oral or IV antibiotics alone. Point being, in a medical culture where it’s difficult to find Lyme literate physicians that can treat you properly, it becomes almost impossible to find a doctor that treats this complex syndrome in an organized, comprehensive manner.
Our group has been working on solving this puzzle for many years. It starts with a proper diagnosis and treatment of all the infections involved: viral, fungal and parasitic co-infections that are often times more difficult to treat than the Lyme disease (Borrelia) itself. All these infections are connected and communicate with each other within your body; if one goes down the other up-regulates its replication until the vicious cycle is broken. Next, an in-depth functional medicine approach is implemented to correct all of the nutritional and amino acid imbalances while addressing old scar tissue, injuries and trauma that the body has suffered. Furthermore, selected medications are delivered in a proprietary method to cross the blood brain barrier and toxic metabolites removed from the central nervous system. This is all done while rebuilding immunity and restoring health. So many patients are confused when it comes to receiving treatment. When you don’t treat Lyme disease complex you leave way too many health issues on the table that are unresolved for the patient; it’s no wonder people don’t get well! In the end, it’s all about the personalized, integrative medical approach that works best for your individual case and getting the health you deserve. If you have any questions about Lyme disease or your current health condition, don’t hesitate to contact us. - See more at: http://envita.com/lyme-disease/stop-treating-lyme-disease-and-treat-the-complex#sthash.tcU2zJze.dpuf
Treating
Lyme disease comprehensively isn’t as easy as it sounds. Our vast
clinical experience uncovers why so many patients suffer needlessly and
never reach best outcomes. With the huge underreported number of cases
and despite a burgeoning growth in public awareness, Lyme disease for so
many is still masked as fibromyalgia, chronic fatigue syndrome, chronic
pain, depression or some other autoimmune disease. Chronic Lyme disease
patients are often referred to as “attention seekers” by most doctors.
It is important to note that Lyme disease can mimic over 360 diseases
with over 300 genetic variations of Borrelia (Lyme disease). Our team
has developed a special proprietary and successful approach that allows
us to target all of the infections and factors involved.
- See more at: http://envita.com/lyme-disease/stop-treating-lyme-disease-and-treat-the-complex#sthash.tcU2zJze.dpuf
Treating
Lyme disease comprehensively isn’t as easy as it sounds. Our vast
clinical experience uncovers why so many patients suffer needlessly and
never reach best outcomes. With the huge underreported number of cases
and despite a burgeoning growth in public awareness, Lyme disease for so
many is still masked as fibromyalgia, chronic fatigue syndrome, chronic
pain, depression or some other autoimmune disease. Chronic Lyme disease
patients are often referred to as “attention seekers” by most doctors.
It is important to note that Lyme disease can mimic over 360 diseases
with over 300 genetic variations of Borrelia (Lyme disease). Our team
has developed a special proprietary and successful approach that allows
us to target all of the infections and factors involved.
- See more at: http://envita.com/lyme-disease/stop-treating-lyme-disease-and-treat-the-complex#sthash.tcU2zJze.dpuf
No comments:
Post a Comment